210 related articles for article (PubMed ID: 26474384)
1. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
[TBL] [Abstract][Full Text] [Related]
2. Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions.
Bai J; Adriani G; Dang TM; Tu TY; Penny HX; Wong SC; Kamm RD; Thiery JP
Oncotarget; 2015 Sep; 6(28):25295-307. PubMed ID: 26231039
[TBL] [Abstract][Full Text] [Related]
3. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.
Aref AR; Huang RY; Yu W; Chua KN; Sun W; Tu TY; Bai J; Sim WJ; Zervantonakis IK; Thiery JP; Kamm RD
Integr Biol (Camb); 2013 Feb; 5(2):381-9. PubMed ID: 23172153
[TBL] [Abstract][Full Text] [Related]
4. Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing.
Yang X; Li K; Zhang X; Liu C; Guo B; Wen W; Gao X
Lab Chip; 2018 Jan; 18(3):486-495. PubMed ID: 29309077
[TBL] [Abstract][Full Text] [Related]
5. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
[TBL] [Abstract][Full Text] [Related]
6. Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model.
Dhiman N; Shagaghi N; Bhave M; Sumer H; Kingshott P; Rath SN
Cytotherapy; 2021 Jan; 23(1):25-36. PubMed ID: 32771259
[TBL] [Abstract][Full Text] [Related]
7. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
8. A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.
Arai K; Eguchi T; Rahman MM; Sakamoto R; Masuda N; Nakatsura T; Calderwood SK; Kozaki K; Itoh M
PLoS One; 2016; 11(9):e0162394. PubMed ID: 27622654
[TBL] [Abstract][Full Text] [Related]
9. Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model.
Jeong K; Yu YJ; You JY; Rhee WJ; Kim JA
Lab Chip; 2020 Feb; 20(3):548-557. PubMed ID: 31942592
[TBL] [Abstract][Full Text] [Related]
10. In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients.
Petanidis S; Kioseoglou E; Domvri K; Zarogoulidis P; Carthy JM; Anestakis D; Moustakas A; Salifoglou A
Int J Biochem Cell Biol; 2016 May; 74():121-34. PubMed ID: 26916505
[TBL] [Abstract][Full Text] [Related]
11. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.
Shang M; Soon RH; Lim CT; Khoo BL; Han J
Lab Chip; 2019 Jan; 19(3):369-386. PubMed ID: 30644496
[TBL] [Abstract][Full Text] [Related]
13. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
16. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
[TBL] [Abstract][Full Text] [Related]
17. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.
Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB
Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of lactic acid on tumor-endothelial cell metabolic coupling in the tumor microenvironment.
Zhu G; Wang D; Li S; Yang X; Cao Y; Wang Y; Niu H
Oncol Lett; 2016 Nov; 12(5):3478-3484. PubMed ID: 27900024
[TBL] [Abstract][Full Text] [Related]
19. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
[TBL] [Abstract][Full Text] [Related]
20. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
Lei KF; Wu MH; Hsu CW; Chen YD
Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
